Background and aim. Elevated levels of secretory immunoglobulin, A have bee
n reported in patients with cholestatic hepatitis. Secretory immunoglobulin
A is present in the biliary and pancreatic tract. Chronic pancreatitis is
a disease characterized by dilatation of Wirsung's duct. The aim of the stu
dy was to evaluate secretary immunoglobulin A levels in patients suffering
from chronic pancreatitis.
Patients and Methods, The study population consisted of 66 consecutive chro
nic pancreatitis patients (55 male, II female; mean age 49.6+/-10 years), 2
6 patients suffering from acute recurrent pancreatitis (9 males, 17 females
, mean age 39.6+/-10.6 years) and 90 healthy controls, pair-matched far sex
and age with the chronic pancreatitis patients. Secretory immunoglobulin A
was determined by enzyme-linked immunosorbent assay, as were serum alanine
transaminase and GGT:
Results, Secretory immunoglobulin A levels were significantly higher in chr
onic pancreatitis patients (35+/-23.7 mg/l) than in those acute recurrent p
ancreatitis group (16.1+/-7.9) and in healthy controls (11.8+/-4.9 mg/l) (p
<0.0001). Secretory immunoglobulin A was significantly higher in chronic pa
ncreatitis patients with steatorrhoea, diabetes and calcifications and in t
hose undergoing pancreatic surgery. Of 61 chronic pancreatitis patients, 14
(23%) had pathological GGT: When only chronic pancreatitis patients with n
ormal GGT levels were analysed, the differences in secretory immunoglobulin
A levels between groups of patients and between chronic pancreatitis subgr
oups remained statistically significant.
Conclusions. This study demonstrates that secretory immunoglobulin A is ele
vated in chronic pancreatitis. its value in the staging of patients needs t
o be further evaluated.